Related Experiment Video
Updated: Jul 9, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Association of insurance with cancer care utilization and outcomes
Elizabeth Ward1, Michael Halpern, Nicole Schrag
1Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA, USA.
Abstract:
Advances in the prevention, early detection, and treatment of cancer have resulted in an almost 14% decrease in the death rates from all cancers combined from 1991 to 2004 in the overall US population, with remarkable declines in mortality for the top 3 causes of cancer death in men (lung, colorectal, and prostate cancer) and 2 of the top 3 cancers in women (breast and colorectal cancer). However, not all segments of the population have benefited equally from this progress, and evidence suggests that some of these differences are related to lack of access to health care. Lack of adequate health insurance appears to be a critical barrier to receipt of appropriate health care services. This article provides an overview of systems of health insurance in the United States, demographic and socioeconomic characteristics associated with health insurance coverage, and economic burdens related to health care among individuals and families. This article also presents data on the association between health insurance status and screening, stage at diagnosis, and survival for breast and colorectal cancer based on analyses of the National Health Interview Survey and the National Cancer Data Base. Although this article focuses on associations between health insurance and cancer care utilization and outcomes, it is important to recognize that barriers to receipt of optimal cancer care are complex and involve patient-level, provider, and health system factors. Evidence presented in this paper suggests that addressing insurance and cost-related barriers to care is a critical component of efforts to ensure that all Americans are able to share in the progress that can be achieved by access to high-quality cancer prevention, early detection, and treatment services.
Insights
Health insurance access significantly impacts cancer care outcomes. Addressing insurance and cost barriers is crucial for equitable cancer prevention, early detection, and treatment for all Americans.
Area of Science:
- Health Services Research
- Cancer Care Disparities
- Health Economics
Background:
- Cancer death rates declined overall in the US, but not equally across all populations.
- Lack of health insurance is a significant barrier to accessing appropriate cancer care.
- Socioeconomic factors and health insurance coverage influence cancer outcomes.
Purpose of the Study:
- To examine the association between health insurance status and cancer care.
- To provide an overview of US health insurance systems and their impact on cancer patients.
- To identify barriers to optimal cancer care related to insurance and cost.
Main Methods:
- Analysis of the National Health Interview Survey (NHIS).
- Analysis of the National Cancer Data Base (NCDB).
- Examination of demographic and socioeconomic characteristics related to insurance coverage.
Main Results:
- Health insurance status is linked to cancer screening, diagnosis stage, and survival rates.
- Lack of insurance creates economic burdens and hinders access to timely care.
- Disparities in cancer outcomes are partly attributable to unequal access to health insurance.
Conclusions:
- Addressing insurance and cost barriers is essential for improving cancer care equity.
- Ensuring access to health insurance is a critical step towards equitable cancer outcomes.
- Comprehensive strategies are needed to overcome complex barriers to optimal cancer care.
Related Concept Videos
Cancer Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include: